Get the Stockscreener App
2.15
3.86%
0.08
After Hours:
2.13
-0.02
-0.93%
NervGen Pharma Corp Stock (NGENF) Forecast
The NervGen Pharma Corp (NGENF) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.1964, representing a -44.35% decrease from the current price of $2.15. The highest analyst price target is $1.1929, and the lowest is $1.20.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NGENF Price Target
Average 1.4607
(-32.06% Downside)
Long-term NGENF price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about NervGen Pharma Corp financial reports and earnings history, NervGen Pharma Corp (NGENF) stock could reach $5.4386 by 2030, $16.02 by 2040 and $20.43 by 2050. See the projected annual prices until 2050 of the NervGen Pharma Corp stock below:
- NervGen Pharma Corp (NGENF) is expected to reach an average price of $10.25 in 2035, with a high prediction of $10.79 and a low estimate of $10.30. This indicates an $376.54% rise from the last recorded price of $2.15.
- NervGen Pharma Corp (NGENF) stock is projected to chart a bullish course in 2040, with an average price target of $15.64, representing an $627.64% surge from its current level. The forecast ranges from a conservative $15.68 to a sky-high $16.02.
- Our analysts predict NervGen Pharma Corp (NGENF) to jump 896.15% by 2045, soaring from $15.60 to an average price of $21.42, potentially reaching $21.64. While $15.60 is the low estimate, the potential upside is significant.
- NervGen Pharma Corp (NGENF) stock is expected to climb by 2050, reaching an average of $19.93, a $827.09% jump from its current level. However, a wide range of estimates exists, with high and low targets of $20.43 and $19.44, respectively, highlighting the market's uncertainty.
NervGen Pharma Corp Stock (NGENF) Year by Year Forecast
NervGen Pharma Corp Stock (NGENF) Price Forecast for 2025
NervGen Pharma Corp Stock (NGENF) is expected to reach an average price of $1.0493 in 2025, with a high prediction of $1.65 and a low estimate of $0.4486. This indicates an -51.20% fall from the last recorded price of $2.15.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $1.13 | $1.20 | $1.1929 | -47.44% |
| June, 2025 | $1.2286 | $1.1757 | $1.1671 | -42.86% |
| July, 2025 | $0.9514 | $1.0214 | $1.1343 | -55.75% |
| August, 2025 | $0.7743 | $0.8143 | $0.9229 | -63.99% |
| September, 2025 | $1.545 | $0.85 | $1.4815 | -28.14% |
| October, 2025 | $1.65 | $1.69 | $1.65 | -23.26% |
| November, 2025 | $1.75 | $1.61 | $1.588 | -18.60% |
| December, 2025 | $1.53 | $1.579 | $1.59 | -28.84% |
NervGen Pharma Corp Stock (NGENF) Price Forecast for 2026
The predicted value for NervGen Pharma Corp (NGENF) in 2026 is set at an average of $1.8721. Estimates vary from a peak of $2.5643 to a trough of $1.18, indicating an -12.92% surge from the present price of $2.15.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.3775 | $1.405 | $1.44 | -35.93% |
| February, 2026 | $1.27 | $1.18 | $1.23 | -40.93% |
| March, 2026 | $2.1649 | $1.31 | $1.9615 | +0.69% |
| April, 2026 | $2.01 | $2.08 | $2.1071 | -6.51% |
| May, 2026 | $1.9821 | $2.0271 | $2.0129 | -7.81% |
| June, 2026 | $1.7286 | $1.7986 | $1.9457 | -19.60% |
| July, 2026 | $1.5057 | $1.5457 | $1.6771 | -29.97% |
| August, 2026 | $2.4936 | $1.57 | $2.4415 | +15.98% |
| September, 2026 | $2.5529 | $2.5929 | $2.5643 | +18.74% |
| October, 2026 | $2.6071 | $2.4786 | $2.4794 | +21.26% |
| November, 2026 | $2.33 | $2.379 | $2.4357 | +8.37% |
| December, 2026 | $2.1318 | $2.1593 | $2.2286 | -0.85% |
NervGen Pharma Corp Stock (NGENF) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for NervGen Pharma Corp (NGENF) is $2.695, with a high forecast of $3.4786 and a low forecast of $1.9114. This indicates an +25.35% increase from the last price of $2.15.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.9786 | $1.9114 | $1.9386 | -7.97% |
| February, 2027 | $3.143 | $2.0071 | $2.9215 | +46.19% |
| March, 2027 | $2.89 | $2.96 | $3.0214 | +34.42% |
| April, 2027 | $2.8164 | $2.8614 | $2.8586 | +31.00% |
| May, 2027 | $2.5057 | $2.5757 | $2.7571 | +16.54% |
| June, 2027 | $2.2371 | $2.2771 | $2.4314 | +4.05% |
| July, 2027 | $3.60 | $2.29 | $3.4015 | +67.44% |
| August, 2027 | $3.4557 | $3.4957 | $3.4786 | +60.73% |
| September, 2027 | $3.4643 | $3.3471 | $3.3709 | +61.13% |
| October, 2027 | $3.2264 | $3.2786 | $3.2814 | +50.06% |
| November, 2027 | $2.8861 | $2.9136 | $3.1112 | +34.24% |
| December, 2027 | $2.6871 | $2.6429 | $2.6471 | +24.98% |
NervGen Pharma Corp Stock (NGENF) Price Forecast for 2028
In 2028, NervGen Pharma Corp (NGENF) is projected to reach an average price of $3.7729, with a high projection of $4.8415 and a low estimate of $2.7043. This indicates an +75.48% rise from the last price of $2.15.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $4.0163 | $2.7043 | $3.8815 | +86.80% |
| February, 2028 | $3.77 | $3.84 | $3.9357 | +75.35% |
| March, 2028 | $3.6507 | $3.6957 | $3.7043 | +69.80% |
| April, 2028 | $3.4214 | $3.4314 | $3.5686 | +59.14% |
| May, 2028 | $2.9686 | $3.0086 | $3.2579 | +38.07% |
| June, 2028 | $4.56 | $3.01 | $4.3615 | +112.09% |
| July, 2028 | $4.3586 | $4.3986 | $4.3929 | +102.72% |
| August, 2028 | $4.3214 | $4.2157 | $4.2623 | +101.00% |
| September, 2028 | $4.0378 | $4.1086 | $4.1271 | +87.80% |
| October, 2028 | $3.6404 | $3.6679 | $3.9112 | +69.32% |
| November, 2028 | $3.3957 | $3.37 | $3.3557 | +57.94% |
| December, 2028 | $5.0173 | $3.4014 | $4.8415 | +133.36% |
NervGen Pharma Corp Stock (NGENF) Price Forecast for 2029
The 2029 price forecast for NervGen Pharma Corp Stock (NGENF) is $4.7658 on average, with a high prediction of $5.8015 and a low estimate of $3.73. This represents an +121.66% increase from the previous price of $2.15.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $4.65 | $4.72 | $4.85 | +116.28% |
| February, 2029 | $4.485 | $4.53 | $4.57 | +108.60% |
| March, 2029 | $4.21 | $4.22 | $4.38 | +95.81% |
| April, 2029 | $3.70 | $3.74 | $4.035 | +72.09% |
| May, 2029 | $5.52 | $3.73 | $5.3215 | +156.74% |
| June, 2029 | $5.3371 | $5.4429 | $5.3071 | +148.24% |
| July, 2029 | $5.1786 | $5.0843 | $5.2314 | +140.86% |
| August, 2029 | $4.8492 | $4.9314 | $4.9729 | +125.54% |
| September, 2029 | $4.4987 | $4.5044 | $4.7112 | +109.24% |
| October, 2029 | $4.1043 | $4.09 | $4.3171 | +90.90% |
| November, 2029 | $5.9544 | $4.0986 | $5.8015 | +176.95% |
| December, 2029 | $5.53 | $5.60 | $5.7643 | +157.21% |
NervGen Pharma Corp Stock (NGENF) Price Forecast for 2030
NervGen Pharma Corp Stock (NGENF) is expected to reach an average price of $5.6043 in 2030, with a high forecast of $6.7615 and a low forecast of $4.4471. This signifies an +160.67% surge from the last price of $2.15.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $5.3193 | $5.3643 | $5.4386 | +147.41% |
| February, 2030 | $4.9986 | $5.0086 | $5.1914 | +132.49% |
| March, 2030 | $4.4728 | $4.7029 | $4.8121 | +108.04% |
| April, 2030 | $6.48 | $4.4471 | $6.2815 | +201.40% |
| May, 2030 | $6.2514 | $6.3686 | $6.2214 | +190.76% |
| June, 2030 | $5.9029 | $5.9529 | $6.1343 | +174.55% |
| July, 2030 | $5.6606 | $5.7543 | $5.8186 | +163.29% |
| August, 2030 | $5.2644 | $5.2701 | $5.5112 | +144.85% |
| September, 2030 | $4.8129 | $4.81 | $5.0714 | +123.85% |
| October, 2030 | $6.8916 | $4.7957 | $6.7615 | +220.54% |
| November, 2030 | $6.4909 | $6.5929 | $6.6786 | +201.90% |
| December, 2030 | $6.1536 | $6.1986 | $6.38 | +186.21% |
0.41%
0.12%
Cap:
|
Volume (24h):